Results 201 to 210 of about 359,344 (313)

Combined blood purification and antiarrhythmic therapy for acute aconitine poisoning with refractory arrhythmias: a case-based mechanistic evaluation and treatment strategy optimization. [PDF]

Eur J Med Res
Yang C, Zou T, Zang QH, Cao W, Suo Y.
europepmc   +1 more source

Drug‐Resistant Sinus Tachycardia as a Dose‐Dependent Side Effect of Spironolactone: A Case Report and Review of the Literature

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Spironolactone is widely used for polycystic ovarian syndrome due to its anti‐androgenic properties. However, rare cardiovascular side effects may occur even in normotensive patients. We report a case of severe palpitations and drug‐resistant sinus tachycardia following high‐dose therapy, emphasizing the need for cautious titration and cardiac
Zahra Abdi, Maryam Chenaghlou, Aysa Rezabakhsh, Laya Hooshmand Gharabagh   +3 more
wiley   +1 more source

Premature Depolarizations and Overdue Questions: Unmet Needs in PVC Cardiomyopathy Research. [PDF]

Circ Arrhythm Electrophysiol
Boyle TA, Frankel DS.
europepmc   +1 more source

Anti‐NMDA Receptor Encephalitis Presenting as Acute Psychosis

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Young adults presenting with acute psychiatric symptoms followed by rapid neurological decline, catatonia, and autonomic instability should prompt consideration of anti–NMDA receptor encephalitis, even without detectable tumors; early recognition and immunotherapy are critical for favorable neurological recovery.
Tatiana Mengistu, Anuj Subedi, Uchenna Unamba, Sajjad Ahmed Khan, Esereoghene Mowoe, Jeremy Lane, Sahar Panah, Huma Kausar   +7 more
wiley   +1 more source

Evaluation of antiarrhythmia drug through QSPR modeling and multi criteria decision analysis. [PDF]

Sci Rep
Iqbal S, Iqbal H, Tarar MA, Hanif MF, Fiidow OA.   +4 more
europepmc   +1 more source

Cardiac digital twins: Modelling the arrhythmic substrate of chemotherapy

The Journal of Physiology, EarlyView.
Radomir Chabiniok, Vlad G. Zaha
wiley   +1 more source

Inhaled Halogen‐Induced Oxidative Renal Damage and Dysfunction: A Lung Heart Kidney Axis

Comprehensive Physiology, Volume 16, Issue 1, February 2026.
Mechanisms of lung‐heart‐kidney interaction in inducing organ injury after chemical inhalation. Acute exposure to halogen gases causes extensive lung injury and acute cardiac damage leading to fatalities. Formation of highly reactive halogenated molecules in the pulmonary bed and their circulation resulting in oxidative stress and inflammation was ...
Juan Xavier Masjoan Juncos, Ahmed Zaky, Wesam Nasser, Amber J. Johns, Iram Zafar, Gajanan R. Jadhav, Jeremy B. Foote, Aftab Ahmad, Anupam Agarwal, Shama Ahmad   +9 more
wiley   +1 more source

Role of implantable loop recorders in optimizing care for patients during and after left ventricular assist device support: a single centre experience. [PDF]

BMC Cardiovasc Disord
Emam AY, El Husseny MWA, Ellithy A, Fawzy N, Elghazoly A, Ahmed E, Selwanos PP, Kamel O.   +7 more
europepmc   +1 more source

BACH2 alleviates immune checkpoint inhibitors‐induced cardiac pyroptosis via transcriptionally promoting GRSF1

Clinical and Translational Medicine, Volume 16, Issue 2, February 2026.
Immune checkpoint inhibitors cause elevated cardiac injuries in humans and mice. ICIs cause myocyte pyroptosis and cardiotoxicity, not via the adaptive immune system BACH2 ameliorates ICIs‐induced pyroptosis through transcriptionally promoting GRSF1. Lipoic acid, as a transcriptional inducer of BACH2, suppresses ICIs‐induced cardiotoxicity.
Mengying Cao, Zilong Liu, Di Zhao, Hongyuan Zhang, Xinjie He, Wenhao Wang, Xiaolin Wang, Cheng Yang, Pan Gao, Yunzeng Zou   +9 more
wiley   +1 more source

Ranolazine in patients with chronic coronary syndromes: real-world data provide new evidence on the antiarrhythmic properties of the drug. [PDF]

Eur Heart J Cardiovasc Pharmacother
Fumagalli S, Dovizio M, Mazzoni S, Degli Esposti L, Santamaria E, Spanalatte G, Fumagalli C, Cagnoni C, Tariello A, Cerbai E, Marchionni N.   +10 more
europepmc   +1 more source